- Drug Pipelines
- April 2024
- 60 Pages
Global
From €1922EUR$2,000USD£1,643GBP
- Clinical Trials
- April 2024
- 40 Pages
Global
From €1201EUR$1,250USD£1,027GBP
- Drug Pipelines
- April 2024
- 60 Pages
Global
From €1201EUR$1,250USD£1,027GBP
- Drug Pipelines
- April 2024
- 60 Pages
Global
From €1922EUR$2,000USD£1,643GBP
- Clinical Trials
- April 2024
- 40 Pages
Global
From €1201EUR$1,250USD£1,027GBP
- Clinical Trials
- April 2024
- 60 Pages
Global
From €1922EUR$2,000USD£1,643GBP
- Report
- September 2023
- 180 Pages
Global
From €5285EUR$5,500USD£4,518GBP
- Report
- March 2024
- 183 Pages
Global
From €3242EUR$3,374USD£2,772GBP
€3602EUR$3,749USD£3,080GBP
- Report
- March 2024
- 150 Pages
Global
From €5717EUR$5,950USD£4,888GBP
- Report
- January 2024
- 200 Pages
Global
From €4804EUR$5,000USD£4,107GBP
- Report
- January 2024
- 150 Pages
Global
From €4660EUR$4,850USD£3,984GBP
- Drug Pipelines
- April 2024
- 180 Pages
Global
From €1922EUR$2,000USD£1,643GBP
- Clinical Trials
- April 2024
- 50 Pages
Global
From €1441EUR$1,500USD£1,232GBP
- Clinical Trials
- April 2024
- 50 Pages
Global
From €1441EUR$1,500USD£1,232GBP
- Report
- June 2023
- 159 Pages
Global
From €7206EUR$7,500USD£6,161GBP
- Report
- November 2023
- 171 Pages
Global
From €2402EUR$2,500USD£2,054GBP
- Report
- December 2023
- 182 Pages
Global
€4799EUR$4,995USD£4,103GBP
- Report
- January 2022
- 148 Pages
Global
From €4084EUR$4,250USD£3,491GBP
- Report
- May 2022
- 151 Pages
Global
From €3060EUR$3,185USD£2,616GBP
€4372EUR$4,550USD£3,738GBP
- Report
- August 2022
- 99 Pages
North America
From €2018EUR$2,100USD£1,725GBP
€2883EUR$3,000USD£2,464GBP
The Neuropathy Drug market is a subset of the Central Nervous System Drugs market, which includes drugs used to treat diseases and disorders of the brain, spinal cord, and peripheral nervous system. Neuropathy drugs are used to treat a variety of conditions, including diabetic neuropathy, postherpetic neuralgia, and chemotherapy-induced peripheral neuropathy. These drugs are typically administered orally, intravenously, or topically, and may include anticonvulsants, antidepressants, and opioids.
The Neuropathy Drug market is highly competitive, with a variety of companies offering products to treat a range of conditions. Some of the major players in the market include Pfizer, GlaxoSmithKline, Novartis, Merck, and Johnson & Johnson. Other companies, such as Eli Lilly, Sanofi, and AstraZeneca, also offer products in this market. Show Less Read more